Dentium CO., LTD (KRX:145720)
South Korea
· Delayed Price · Currency is KRW 52,700
+3,300 (6.68%)
Last updated: Mar 10, 2026, 11:52 AM KST
Dentium CO., LTD Revenue
Dentium CO., LTD had revenue of 78.22B KRW in the quarter ending September 30, 2025, a decrease of -17.38%. This brings the company's revenue in the last twelve months to 356.03B, down -13.86% year-over-year. In the year 2024, Dentium CO., LTD had annual revenue of 407.81B with 3.72% growth.
Revenue (ttm)
356.03B
Revenue Growth
-13.86%
P/S Ratio
1.08
Revenue / Employee
417.39M
Employees
853
Market Cap
385.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 407.81B | 14.62B | 3.72% |
| Dec 31, 2023 | 393.19B | 37.32B | 10.49% |
| Dec 31, 2022 | 355.87B | 64.34B | 22.07% |
| Dec 31, 2021 | 291.53B | 61.78B | 26.89% |
| Dec 31, 2020 | 229.75B | -22.84B | -9.04% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,556.97B |
| Celltrion | 3,895.99B |
| ALTEOGEN | 202.18B |
| Sam Chun Dang Pharm. | 220.74B |
| BINEX | 165.64B |
| ToolGen | 1.07B |
| Anterogen.Co.,Ltd. | 7.32B |
| T&L Co., Ltd. | 177.27B |